JM Financial has issued a new recommendation for Dr. Reddy's Laboratories, forecasting a potential upside of 17.28% with a target price of Rs 8010.00. The stock was recommended at Rs 6879.00 and is currently trading at Rs 6829.95. This analysis highlights the positive outlook provided by JM Financial for investors in the pharmaceutical company.